Trademark Overview
On Tuesday, December 10, 2024, a trademark application was filed for DRP3 with the United States Patent and Trademark Office. The USPTO has given the DRP3 trademark a serial number of 98894373. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 10, 2024. This trademark is owned by Acadia Pharmaceuticals, Inc.. The DRP3 trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Paper & Printed Material Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services, namely, providing educational programs in the nature of classes, seminars, and workshops about neurodegenerative diseases and disorders and dementia and diagnosis, identification, management, treatment, and patient support options for these conditions; multimedia educational services in the nature of recording and production services in the fields of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management distributed via various platforms across multiple forms of transmission media; providing on-line newsletters in the field of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management; online non-downloadable electronic publications in the nature of brochures, pamphlets, newsletters, articles and guideb...
Downloadable electronic publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment
Printed publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment; printed questionnaires on medical issues
Promoting awareness of patient support offerings for neurodegenerative diseases and disorders and dementia; business administrative services for medical referrals
Medical consulting with respect to neurodegenerative diseases and disorders and dementia, including dementia-related psychosis and their identification and treatment; providing medical online information for health care providers and patients in the field of neurodegenerative diseases and disorders and dementia; medical informational support services, namely, providing medical information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients and healthcare professionals all related to neurodegenerative diseases and disorders and dementia
Testing, inspection, research, and development of diagnostic tests and questionnaires for symptoms of dementia-related psychosis, including hallucinations and delusions associated with dementia-related psychosis